A Study to Investigate if Long Acting Cabotegravir (CAB) and Lenacapavir (LEN) Injections Are Tolerable and Acceptable When Administered to Healthy Adults Without HIV
This study will evaluate the tolerability and acceptability of injection site reactions (ISRs) of two long-acting (LA) injectables. Additional characteristics of the ISRs will be investigated and described as well as safety outcomes.
Protocol Amendment History
2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-05-05; most recent amendment 2025-11-21.
Status change: Recruiting → Active, Not Recruiting2025-07-16